Sosei Committed to Becoming a Japan-Based Global Biopharma: Vice President Akihiro Matsuura

“Sosei is unique in that it does not confine itself to one particular technology,” said Akihiro Matsuura, vice president, Product Development Div and Non-Clinical Development Dept of Sosei Co., Ltd. at the latest monthly meeting of the Japan Pharmaceutical Licensing...read more